JMJD6 and nasopharyngeal carcinoma: Consistent with our prediction results, CCNB2 knockdown activated the p53 pathway in NPC cells, which was mitigated by JMJD6, preliminarily confirming the JMJD6/CCNB2/p53 axis in NPC.